Lentiviral delivery of biglycan promotes proliferation and increases osteogenic potential of bone marrow-derived mesenchymal stem cells in vitro

Journal of Molecular Histology

Volumn 44, Issue 4, 2013, Pages 423-431

  Wu, Bo ^a   Ma, Xu ^a   Zhu, Damu ^a   Liu, Ye ^a   Sun, Zhuqing ^a   Liu, Suyuan ^a   Xue, Bing ^a   Du, Mingchang ^a   Yin, Ximeng ^a  

^a Shenyang Orthopaedics Hospital   (China)

Author keywords

Biglycan; Mesenchymal stem cells; Osteogenic potential; Proliferation; Transforming growth factor 1

Indexed keywords

ALKALINE PHOSPHATASE; BIGLYCAN; COLLAGEN TYPE 1; LENTIVIRUS VECTOR; MESSENGER RNA; OSTEOCALCIN; PROTEIN P21; PROTEIN P27; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ALKALINE PHOSPHATASE; ANIMALS; BIGLYCAN; BONE MARROW CELLS; CELL PROLIFERATION; CELL SEPARATION; COLLAGEN; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LENTIVIRUS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84880922481     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-013-9497-4     Document Type: Article

References (30)

1. Bi Y, Stuelten CH, Kilts T, Wadhwa S, Iozzo RV, Robey PG, Chen XD, Young MF (2005) Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J Biol Chem 280(34):30481-30489. doi: 10.1074/jbc.M500573200 (Pubitemid 41216232)
2. Bolton K, Segal D, Walder K (2012) The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes. Biologics 6:67-72. doi: 10.2147/BTT.S27925
3. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B (2006) Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7:14. doi: 10.1186/1471-2121-7-14
4. Chen XD, Shi S, Xu T, Robey PG, Young MF (2002) Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells. J Bone Miner Res 17(2):331-340. doi: 10.1359/jbmr.2002.17.2.331 (Pubitemid 34087666)
5. Donzelli E, Salvade A, Mimo P, Vigano M, Morrone M, Papagna R, Carini F, Zaopo A, Miloso M, Baldoni M, Tredici G (2007) Mesenchymal stem cells cultured on a collagen scaffold: in vitro osteogenic differentiation. Arch Oral Biol 52(1):64-73. doi: 10.1016/j.archoralbio.2006.07.007 (Pubitemid 44853923)
6. Gotte M, Sofeu Feugaing DD, Kresse H (2004) Biglycan is internalized via a chlorpromazine-sensitive route. Cell Mol Biol Lett 9(3):475-481 (Pubitemid 39313073)
7. Gu X, Ma Y, Xiao J, Zheng H, Song C, Gong Y, Xing X (2012) Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers. Clin Exp Med 12(3):195-199. doi: 10.1007/s10238-011-0155-4
8. Hering S, Isken E, Knabbe C, Janott J, Jost C, Pommer A, Muhr G, Schatz H, Pfeiffer AF (2001) TGFbeta1 and TGFbeta2 mRNA and protein expression in human bone samples. Exp Clin Endocrinol Diabetes 109(4):217-226. doi: 10.1055/s-2001-15109 (Pubitemid 32577689)
9. Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM, Bunnell BA (2006) Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 99(5):1285-1297. doi: 10.1002/jcb.20904
10. Karaoz E, Aksoy A, Ayhan S, Sariboyaci AE, Kaymaz F, Kasap M (2009) Characterization of mesenchymal stem cells from rat bone marrow: ultrastructural properties, differentiation potential and immunophenotypic markers. Histochem Cell Biol 132(5):533-546. doi: 10.1007/s00418-009-0629-6
11. Kimelman N, Pelled G, Gazit Z, Gazit D (2006) Applications of gene therapy and adult stem cells in bone bioengineering. Regen Med 1(4):549-561. doi: 10.2217/17460751.1.4.549
12. Knippenberg M, Helder MN, Doulabi BZ, Bank RA, Wuisman PI, Klein-Nulend J (2009) Differential effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on gene expression of collagen-modifying enzymes in human adipose tissue-derived mesenchymal stem cells. Tissue Eng Part A 15(8):2213-2225. doi: 10.1089/ten.tea.2007.0184
13. Kocamaz E, Gok D, Cetinkaya A, Tufan AC (2012) Implication of C-type natriuretic peptide-3 signaling in glycosaminoglycan synthesis and chondrocyte hypertrophy during TGF-beta1 induced chondrogenic differentiation of chicken bone marrow-derived mesenchymal stem cells. J Mol Histol 43(5):497-508. doi: 10.1007/s10735-012-9430-2
14. Lennon DP, Caplan AI (2006) Isolation of rat marrow-derived mesenchymal stem cells. Exp Hematol 34(11):1606-1607. doi: 10.1016/j.exphem.2006.07.015 (Pubitemid 44548125)
15. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402-408. doi: 10.1006/meth.2001.1262 (Pubitemid 34164012)
16. Marie PJ, Fromigue O (2006) Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen Med 1(4):539-548. doi: 10.2217/17460751.1.4.539
17. Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS, Tanavde V (2008) PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112(2):295-307. doi: 10.1182/blood-2007-07-103697
18. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143-147 (Pubitemid 29282067)
19. Schaefer L, Iozzo RV (2008) Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 283(31):21305-21309. doi: 10.1074/jbc.R800020200
20. Schaefer L, Hausser H, Altenburger M, Ugorcakova J, August C, Fisher LW, Schaefer RM, Kresse H (1998) Decorin, biglycan and their endocytosis receptor in rat renal cortex. Kidney Int 54(5):1529-1541. doi: 10.1046/j.1523-1755.1998. 00149.x (Pubitemid 28502895)
21. Shibata KR, Aoyama T, Shima Y, Fukiage K, Otsuka S, Furu M, Kohno Y, Ito K, Fujibayashi S, Neo M, Nakayama T, Nakamura T, Toguchida J (2007) Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells 25(9):2371-2382. doi: 10.1634/stemcells.2007-0225 (Pubitemid 47480497)
22. Shimizu-Hirota R, Sasamura H, Kuroda M, Kobayashi E, Hayashi M, Saruta T (2004) Extracellular matrix glycoprotein biglycan enhances vascular smooth muscle cell proliferation and migration. Circ Res 94(8):1067-1074. doi: 10.1161/01.RES.0000126049.79800.CA (Pubitemid 38579701)
23. Song R, Zeng Q, Ao L, Yu JA, Cleveland JC, Zhao KS, Fullerton DA, Meng X (2012) Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2. Arterioscler Thromb Vasc Biol 32(11):2711-2720. doi: 10.1161/ATVBAHA.112.300116
24. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, Ho AD (2008) Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE 3(5):e2213. doi: 10.1371/journal.pone.0002213
25. Wang B, Li GX, Zhang SG, Wang Q, Wen YG, Tang HM, Zhou CZ, Xing AY, Fan JW, Yan DW, Qiu GQ, Yu ZH, Peng ZH (2011) Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer. Exp Biol Med (Maywood) 236(11):1247-1253. doi: 10.1258/ebm.2011.011124
26. Ward M, Ajuwon KM (2011) Regulation of pre-adipocyte proliferation and apoptosis by the small leucine-rich proteoglycans, biglycan and decorin. Cell Prolif 44(4):343-351. doi: 10.1111/j.1365-2184.2011.00763.x
27. Weber CK, Sommer G, Michl P, Fensterer H, Weimer M, Gansauge F, Leder G, Adler G, Gress TM (2001) Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology 121(3):657-667 (Pubitemid 32822581)
28. Yamachika E, Tsujigiwa H, Matsubara M, Hirata Y, Kita K, Takabatake K, Mizukawa N, Kaneda Y, Nagatsuka H, Iida S (2012) Basic fibroblast growth factor supports expansion of mouse compact bone-derived mesenchymal stem cells (MSCs) and regeneration of bone from MSC in vivo. J Mol Histol 43(2):223-233. doi: 10.1007/s10735-011-9385-8
29. Yamamoto K, Ohga N, Hida Y, Maishi N, Kawamoto T, Kitayama K, Akiyama K, Osawa T, Kondoh M, Matsuda K, Onodera Y, Fujie M, Kaga K, Hirano S, Shinohara N, Shindoh M, Hida K (2012) Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells. Br J Cancer 106(6):1214-1223. doi: 10.1038/bjc.2012.59
30. Young MF, Bi Y, Ameye L, Chen XD (2002) Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj J 19(4-5):257-262. doi: 10.1023/A:1025336114352 (Pubitemid 37174553)